4128 logo

Microbio Co., Ltd. Stock Price

TPEX:4128 Community·NT$12.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

4128 Share Price Performance

NT$21.10
-17.65 (-45.55%)
NT$21.10
-17.65 (-45.55%)
Price NT$21.10

4128 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

1 Risk
1 Reward

Microbio Co., Ltd. Key Details

NT$1.8b

Revenue

NT$1.1b

Cost of Revenue

NT$715.0m

Gross Profit

NT$2.1b

Other Expenses

-NT$1.3b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-2.28
39.44%
-73.91%
0%
View Full Analysis

About 4128

Founded
2000
Employees
n/a
CEO
Tzen-Wen Chen
WebsiteView website
www.twmicrobio.com

Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia. It also involved in the trading of organic foods; sale of beverages; provision of technology development, transfer, and consultation services; and publishing of magazine, as well as offers business consulting services. Microbio Co., Ltd. was incorporated in 2000 and is based in Taipei City, Taiwan.

Recent 4128 News & Updates

Recent updates

No updates

Microbio Co., Ltd. Competitors